4.66
Evoke Pharma Inc stock is traded at $4.66, with a volume of 15,120.
It is up +1.53% in the last 24 hours and down -9.86% over the past month.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
See More
Previous Close:
$4.59
Open:
$4.55
24h Volume:
15,120
Relative Volume:
0.08
Market Cap:
$7.26M
Revenue:
$8.62M
Net Income/Loss:
$-6.15M
P/E Ratio:
-0.4225
EPS:
-11.03
Net Cash Flow:
$-5.32M
1W Performance:
-0.43%
1M Performance:
-9.86%
6M Performance:
+111.82%
1Y Performance:
-10.21%
Evoke Pharma Inc Stock (EVOK) Company Profile
Name
Evoke Pharma Inc
Sector
Phone
858-345-1494
Address
420 STEVENS AVENUE, SOLANA BEACH, CA
Compare EVOK with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
EVOK
Evoke Pharma Inc
|
4.66 | 7.15M | 8.62M | -6.15M | -5.32M | -11.03 |
![]()
ZTS
Zoetis Inc
|
142.26 | 62.54B | 9.39B | 2.62B | 2.22B | 5.8121 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 43.30B | 29.96B | 957.25M | 4.77B | 0.2956 |
![]()
HLN
Haleon Plc Adr
|
9.08 | 40.08B | 14.26B | 1.98B | 2.47B | 0.4327 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.02 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
![]()
UTHR
United Therapeutics Corp
|
440.06 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jun-22-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
Mar-05-19 | Downgrade | H.C. Wainwright | Buy → Neutral |
Mar-08-18 | Reiterated | B. Riley FBR, Inc. | Buy |
Oct-19-17 | Resumed | FBR & Co. | Buy |
Mar-16-17 | Reiterated | Rodman & Renshaw | Buy |
Jan-30-17 | Upgrade | Laidlaw | Neutral → Buy |
Jan-05-17 | Upgrade | Rodman & Renshaw | Neutral → Buy |
Dec-23-16 | Reiterated | Rodman & Renshaw | Neutral |
Jul-19-16 | Reiterated | FBR Capital | Outperform |
Jul-19-16 | Downgrade | Noble Financial | Buy → Hold |
Jul-18-16 | Downgrade | Rodman & Renshaw | Buy → Neutral |
Mar-16-16 | Initiated | Northland Capital | Outperform |
Mar-14-16 | Reiterated | Ascendiant Capital Markets | Buy |
Feb-17-16 | Resumed | FBR Capital | Outperform |
Dec-03-14 | Reiterated | MLV & Co | Buy |
Nov-07-14 | Initiated | MLV & Co | Buy |
Apr-22-14 | Initiated | Laidlaw | Buy |
Nov-19-13 | Initiated | Aegis Capital | Buy |
View All
Evoke Pharma Inc Stock (EVOK) Latest News
How currency fluctuations impact Evoke Pharma Inc. stockJuly 2025 Update & Technical Buy Zone Confirmation - newser.com
Evoke Pharma Inc.’s volatility index tracking explainedSwing Trade & Expert Curated Trade Setups - newser.com
What valuation multiples suggest for Evoke Pharma Inc. stockJuly 2025 Reactions & High Yield Stock Recommendations - newser.com
Does Evoke Pharma Inc. fit your quant trading modelGlobal Markets & Technical Buy Zone Confirmations - newser.com
Real time alert setup for Evoke Pharma Inc. performanceDay Trade & Free Community Consensus Stock Picks - newser.com
Using data tools to time your Evoke Pharma Inc. exitMarket Trend Report & Consistent Income Trade Ideas - newser.com
Short interest data insights for Evoke Pharma Inc.Dollar Strength & Real-Time Market Trend Scan - newser.com
What to expect from Evoke Pharma Inc. in the next 30 daysDay Trade & Daily Profit Maximizing Tips - newser.com
Weiss Ratings Reiterates “Sell (E+)” Rating for Evoke Pharma (NASDAQ:EVOK) - Defense World
Will Evoke Pharma Inc. stock recover after recent drop2025 Price Action Summary & Verified Momentum Stock Ideas - newser.com
Sector ETF performance correlation with Evoke Pharma Inc.Trade Entry Report & Verified Entry Point Signals - newser.com
Institutional scanner results for Evoke Pharma Inc.Breakout Watch & Verified High Yield Trade Plans - newser.com
Will Evoke Pharma Inc. stock return to pre crisis levelsJuly 2025 Snapshot & Reliable Intraday Trade Alerts - newser.com
How to monitor Evoke Pharma Inc. with trend dashboardsRecession Risk & Safe Capital Investment Plans - newser.com
What Fibonacci levels say about Evoke Pharma Inc. rebound2025 Market Overview & Growth Focused Investment Plans - newser.com
Is Evoke Pharma Inc a good long term investmentLarge Cap Stability Picks & Register for the Next Free Workshop - earlytimes.in
News impact scoring models applied to Evoke Pharma Inc.2025 Market Trends & Technical Confirmation Trade Alerts - newser.com
Will Evoke Pharma Inc. continue its uptrend2025 Price Targets & AI Driven Stock Movement Reports - newser.com
Evoke Pharma Inc Stock (EVOK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):